CLVS

Clovis Oncology, Inc.

Delisted

CLVS was delisted on the 20th of December, 2022.

138 hedge funds and large institutions have $1.31B invested in Clovis Oncology, Inc. in 2014 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 58 increasing their positions, 38 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
138
Holders Change
-2
Holders Change %
-1.43%
% of All Funds
4.01%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.2%
New
23
Increased
58
Reduced
38
Closed
25
Calls
$31M
Puts
$24.6M
Net Calls
+$6.38M
Net Calls Change
+$17.3M
Name Holding Trade Value Shares
Change
Shares
Change %
CCM
151
Cadian Capital Management
New York
-$729K -17,604 Closed
Two Sigma Advisers
152
Two Sigma Advisers
New York
-$530K -12,806 Closed
NCCM
153
Nine Chapters Capital Management
New Jersey
-$530K -12,800 Closed
AQR Capital Management
154
AQR Capital Management
Connecticut
-$475K -11,466 Closed
QT
155
Quantbot Technologies
New York
-$420K -10,150 Closed
Group One Trading
156
Group One Trading
Illinois
-$276K -6,666 Closed
TAM
157
Tocqueville Asset Management
New York
-$174K -4,200 Closed
ARC
158
Absolute Return Capital
Massachusetts
-$142K -3,431 Closed
VFA
159
Virtus Fund Advisers
Connecticut
-$87K -2,105 Closed
GSC
160
Ground Swell Capital
South Carolina
-$39K -950 Closed
Bank of Montreal
161
Bank of Montreal
Ontario, Canada
-$19K -450 Closed
SEC
162
Seven Eight Capital
New York
-$8K -200 Closed
Creative Planning
163
Creative Planning
Kansas
-$4K -100 Closed